blindness with tirzepatide Diabetes: May Lower Risk of Diabetic Retinopathy Doctor Explains GLP 1 Blindness

Visual changes (blurred vision, diplopia)

Of course, there are limits, and the hypercapitalism exemplified by Dr

A couple of studies found no benefits of B12 for lowering homocysteine in HD patients, one used oral B12, 2000 g three times per week for 6 weeks, 55 the other used methyl-B12 i.m

Still others find that combining medication with intensive behavioral changesconsistent exercise, protein-focused nutrition, sleep optimizationextends weight-loss durability after discontinuation

These and other risks are described more fully in PMGCs filings with the United States Securities and Exchange Commission (SEC), including the Risk Factors section of the Companys Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and its other documents subsequently filed with or furnished to the SEC